Missouri Regulatory Affairs Specialist
Examination Practice Test Questions With
Correct Answers (Verified Answers) Plus
Rationales 2026 Q&A | Instant Download Pdf
1. A primary responsibility of a Regulatory Affairs Specialist in the
pharmaceutical industry is to:
A. Market pharmaceutical products directly to consumers
B. Ensure compliance with applicable laws and regulatory
requirements
C. Manufacture active pharmaceutical ingredients
D. Conduct surgical procedures in clinical trials
Answer: B
Rationale: A Regulatory Affairs Specialist ensures that products
comply with all applicable local, state, and federal regulations.
They do not engage in marketing, manufacturing, or clinical
procedures.
,2. Which U.S. federal agency is primarily responsible for regulating
pharmaceuticals?
A. CDC
B. OSHA
C. FDA
D. DEA
Answer: C
Rationale: The Food and Drug Administration (FDA) regulates
drugs, biologics, and medical devices in the United States.
3. Good Manufacturing Practices (GMP) are designed to ensure that
products are:
A. Marketed aggressively
B. Safe, consistent, and high quality
C. Sold at the lowest possible cost
D. Exempt from regulatory review
Answer: B
Rationale: GMP guidelines ensure consistent production and
quality control of regulated products.
,4. What is the primary purpose of an Investigational New Drug (IND)
application?
A. To approve a drug for marketing
B. To allow human clinical trials to begin
C. To register a trademark
D. To distribute drugs internationally
Answer: B
Rationale: An IND allows a drug sponsor to legally conduct
clinical trials in humans.
5. Which phase of clinical trials primarily assesses safety in a small
group of healthy volunteers?
A. Phase I
B. Phase II
C. Phase III
D. Phase IV
Answer: A
Rationale: Phase I trials focus on safety, dosage, and side effects
in a small population.
, 6. The Code of Federal Regulations (CFR) Title 21 relates to:
A. Transportation safety
B. Food and drugs
C. Environmental protection
D. Criminal law
Answer: B
Rationale: Title 21 CFR governs food and drug regulations in the
United States.
7. What does “compliance” in regulatory affairs primarily refer to?
A. Following marketing trends
B. Meeting regulatory and legal requirements
C. Increasing production speed
D. Reducing staffing costs
Answer: B
Rationale: Compliance refers to adherence to laws, regulations,
and guidelines.
8. Which document outlines how a clinical trial will be conducted?
A. Standard Operating Procedure (SOP)
B. Clinical Trial Protocol
Examination Practice Test Questions With
Correct Answers (Verified Answers) Plus
Rationales 2026 Q&A | Instant Download Pdf
1. A primary responsibility of a Regulatory Affairs Specialist in the
pharmaceutical industry is to:
A. Market pharmaceutical products directly to consumers
B. Ensure compliance with applicable laws and regulatory
requirements
C. Manufacture active pharmaceutical ingredients
D. Conduct surgical procedures in clinical trials
Answer: B
Rationale: A Regulatory Affairs Specialist ensures that products
comply with all applicable local, state, and federal regulations.
They do not engage in marketing, manufacturing, or clinical
procedures.
,2. Which U.S. federal agency is primarily responsible for regulating
pharmaceuticals?
A. CDC
B. OSHA
C. FDA
D. DEA
Answer: C
Rationale: The Food and Drug Administration (FDA) regulates
drugs, biologics, and medical devices in the United States.
3. Good Manufacturing Practices (GMP) are designed to ensure that
products are:
A. Marketed aggressively
B. Safe, consistent, and high quality
C. Sold at the lowest possible cost
D. Exempt from regulatory review
Answer: B
Rationale: GMP guidelines ensure consistent production and
quality control of regulated products.
,4. What is the primary purpose of an Investigational New Drug (IND)
application?
A. To approve a drug for marketing
B. To allow human clinical trials to begin
C. To register a trademark
D. To distribute drugs internationally
Answer: B
Rationale: An IND allows a drug sponsor to legally conduct
clinical trials in humans.
5. Which phase of clinical trials primarily assesses safety in a small
group of healthy volunteers?
A. Phase I
B. Phase II
C. Phase III
D. Phase IV
Answer: A
Rationale: Phase I trials focus on safety, dosage, and side effects
in a small population.
, 6. The Code of Federal Regulations (CFR) Title 21 relates to:
A. Transportation safety
B. Food and drugs
C. Environmental protection
D. Criminal law
Answer: B
Rationale: Title 21 CFR governs food and drug regulations in the
United States.
7. What does “compliance” in regulatory affairs primarily refer to?
A. Following marketing trends
B. Meeting regulatory and legal requirements
C. Increasing production speed
D. Reducing staffing costs
Answer: B
Rationale: Compliance refers to adherence to laws, regulations,
and guidelines.
8. Which document outlines how a clinical trial will be conducted?
A. Standard Operating Procedure (SOP)
B. Clinical Trial Protocol
